Inhibitor Therapeutics, Inc. Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities
Inhibitor Therapeutics, Inc. (INTI) had Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities of $422.32 thousand as of 2012-12-31, per its 10-K filed 2014-04-15.
Discontinued › Notes › Liabilities Subject to Compromise
us-gaap:LiabilitiesSubjectToCompromiseAccountsPayableAndAccruedLiabilities · last filed 2014-04-15
- 2012-12-31: Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities $422.32K.
| Period end | Liabilities Subject to Compromise, Accounts Payable and Accrued Liabilities |
|---|---|
| 2012-12-31 | $422.32K 10-K · filed 2014-04-15 |